CD4 and myeloid sarcoma: Population II (CD45RA−Foxp3hi) within the CD4+ gate showed a significant increase with age in MS patients (R2 = 0.237, p = 0.003), but not in HD (R2 = 0.034, p = 0.436)(data not shown).